Pricing Log in Create free account

Faeth Therapeutics, Inc. (FTH) vs Ovid Therapeutics (OVID)

Faeth Therapeutics, Inc. and Ovid Therapeutics are both Biotechnology companies. Faeth Therapeutics, Inc. and Ovid Therapeutics are of similar size ($514.8M and $503.9M). Faeth Therapeutics, Inc. has the higher net margin (0.00% vs −439.1%) and the higher return on invested capital (0.00% vs −35.1%). Across the 14 metrics below, Faeth Therapeutics, Inc. leads on 8 and Ovid Therapeutics on 6.

Valuation

Metric FTH OVID Biotechnology median
P/E n/m n/m 10.60
P/S n/m 72.14 9.40
P/B 3.51 2.70 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 58.65 9.02
Earnings yield (635.04%) (7.85%) (32.88%)
Free cash flow yield (7.66%) (9.69%) (23.13%)

Profitability

Metric FTH OVID Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (742.97%) 0.00%
Net margin 0.00% (439.11%) 0.00%
Free cash flow margin 0.00% (697.30%) 0.00%
Return on equity (229.61%) (25.97%) (51.96%)
Return on assets (204.67%) (22.30%) (46.06%)
Return on invested capital 0.00% (35.11%) 0.00%

Growth

Metric FTH OVID Biotechnology median
Revenue growth (TTM) — 1,333.39% 6.76%
EPS growth (last fiscal year) 30.33% 37.84% 29.88%
Revenue growth, 5-year CAGR — (10.48%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FTH OVID Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 16.12 12.39 4.97
Net debt to EBITDA 0.96 1.37 1.01

Dividend

Metric FTH OVID Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric FTH OVID Biotechnology median
Market cap 514.81m 503.87m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack